TITLE

Filling the void

AUTHOR(S)
Leiderman, Ira
PUB. DATE
December 2001
SOURCE
Pharmaceutical Executive;Dec2001, Vol. 21 Issue 12, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the role of the pharmaceutical industry in providing funds for stem cell research in the United States. Implication of the limits placed by the government on financing for stem cell research; Significance of investing in or acquiring Nasdaq companies; Companies to watch for in 2002.
ACCESSION #
5741455

Tags: STEM cells;  PHARMACEUTICAL industry;  RESEARCH grants

 

Related Articles

  • Stem-cell politics.  // Nature Genetics;Oct2001, Vol. 29 Issue 2, p101 

    Editorial. Comments on the implications of President George W. Bush's announcement that the U.S. federal government will fund research on 64 embryonic human stem cell lines. Alliance of biologists and disease advocates in favor of the research; Endorsement of the coalition to access more...

  • The New York Stem Cell Foundation awards $10.5 mln to 7 new NYSCF -- Robertson Investigators.  // Biomedical Market Newsletter;10/17/2011, Vol. 21, p700 

    The article reports on the grants worth 10.5 million U.S. dollar that is given by the New York Stem Cell Foundation to 7 of the country's young and leading scientist wherein each will receive 1.5 million dollars for expansion, training, and support for innovative research.

  • Prop. 71 May Make S.D. a Stem Cell Research Mecca. Webb, Marion // San Diego Business Journal;11/8/2004, Vol. 25 Issue 45, p7 

    No abstract available.

  • The Debate Over: Stem Cells Gets Hot. D'Agnese, Joseph // Discover;Jan2002, Vol. 23 Issue 1, p56 

    Focuses on the controversy over stem cell research in the United States. Advantages in using embryonic stem cells; Funds granted to stem cells research; Sufficiency of embryos in medical treatment. INSETS: NEWS FROM THE WORLD OF ADULT STEM-CELL RESEARCH.;NEWS OF EMBRYONIC STEM CELLS.;A REVERSE...

  • R & D. Smith, Davis N.; Gopal, Kevin // Pharmaceutical Executive;Mar2001, Vol. 21 Issue 3, p130 

    Presents news briefs on research and development in the pharmaceutical industry as of March 2001. Consequences of the opposition of United States President George W. Bush's administration to finance embryonic stem cell research; Results of the report `The Fruits of Genomics' on the development...

  • New Jersey's Edifice Complex.  // njbiz;8/8/2005, Vol. 18 Issue 32, p10 

    Comments on the efforts of the state of New Jersey to become a leader in the field of stem cell research. Factors that stalled the state's efforts; Background on stem cell research in California and Massachusetts; Benefit of the state's pharmaceutical sector.

  • DESIGNING AN EFFECTIVE PROGRAM OF STATE-SPONSORED HUMAN EMBRYONIC STEM CELL RESEARCH. Noll, Roger G. // Berkeley Technology Law Journal;Summer2006, Vol. 21 Issue 3, p1143 

    The article discusses the methods of establishing an effective program of state-sponsored human embryonic stem cell research as depicted in the creation of the California Institute for Regenerative Medicine. One of the methods is the elimination of "pork barrel" effects on the funding for these...

  • California Embryonic Stem Cell Research Agency Will Issue Bonds.  // National Right to Life News;Jun2007, Vol. 34 Issue 6, p7 

    No abstract available.

  • UCI Set to Receive S3.3M Grant for Stem Cell Research. Reed, Vita // Orange County Business Journal;2/9/2009, Vol. 32 Issue 6, p12 

    The article reports on the $3.3 million grant that the University of California (UC) is set to receive from the state as a way to boost its training program for stem cell research in Irvine. It states that the California Institute for Regenerative Medicine tentatively approved UC's three-year...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics